Timothy Lindquist, MD
NPI 1124281431 · Ophthalmology Physician · San Antonio, TX
Enrolled with Medicare as Practitioner - Ophthalmology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1124281431
- Entity type
- Individual
- Primary specialty
- Ophthalmology PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- Sole proprietor
- Yes
- License
- 9406986 (KS)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
17 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
2 documented practice locations
- Medicare service volume (vs. specialty peers)25% of score
1,479 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Complete Exam of Visual System92014 | 402 | $119 |
| Established Patient Problem Focused Exam of Visual System92012 | 242 | $84 |
| Imaging of Retina92134 | 120 | $38 |
| Measurement of Corneal Curvature and Depth of Eye92136 | 119 | $38 |
| Exam of Visual Field With Extended Testing92083 | 106 | $60 |
| Imaging of Optic Nerve92133 | 101 | $33 |
| New Patient Complete Exam of Visual System92004 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 8 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Latanoprost | 75 | 28 |
| Prednisolone Acetate | 37 | 27 |
| Dorzolamide Hcl/Timolol Maleatbrand: Dorzolamide-Timolol | 26 | — |
| Neomycin/Polymyxin B/Dexamethabrand: Neomycin-Polymyxin-Dexameth | 25 | 21 |
| Cyclosporinebrand: Restasis | 24 | 12 |
| Dorzolamide Hcl | 23 | — |
| Cyclosporine | 14 | — |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$457 across 12 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Additional practice locations (1)
- 8300 College Blvd.Suite 201Overland Park, KS 66210Phone: (816) 234-3000
Registry dates
- Enumerated
- 2008-07-07
- Last updated
- 2023-04-10
- Certified
- 2023-04-10
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.